ADHDComorb Tracker: Guided Med Trials + Executive Function Starter for PCOS+ADHD
Comorbid ADHD, depression, PCOS, and low iron create executive dysfunction that blocks booking doctors, running med trials, tracking side effects, and completing basic self-care or schoolwork, leading to academic failure and repeated self-doubt about diagnosis.
Is the problem real?
Severe ADHD-depression comorbidity compounded by PCOS, insulin resistance, and low iron, causing executive dysfunction, academic failure, self-doubt about diagnosis, and inability to initiate treatment or basic self-care.
EVIDENCE
Worst depression slump I've ever had
Worst depression slump I've ever had
Worst depression slump I've ever had
Who feels this pain?
TARGET USERS
Female or AFAB college students in multi-month depression slumps struggling to initiate ADHD treatment, track symptoms across hormonal/insulin factors, and complete overdue academic work due to severe executive dysfunction.
Context
Current Workarounds
Where's the gap?
EXISTING SOLUTION GAPS
OPPORTUNITY & VALUE
Repeated severe med trial failures (5-6 meds), executive paralysis blocking appointments, diagnostic doubt cycles, academic collapse.
Explicitly designed for ADHD+PCOS+Depression comorbidity with hormonal-aware logging and ultra-low executive load entry points, unlike general ADHD or PCOS apps.
A simple mobile web app that provides one-tap symptom logging tied to cycle/insulin factors, guided micro-trials for ADHD meds with side-effect safety nets, daily executive function prompts calibrated to energy levels, and PCOS-specific validation modules to reduce diagnostic doubt.
How does it make money?
MONETIZATION
Model
Users repeatedly mention trying 5-6 meds and losing months to dysfunction; they already pay for online classes and supplements. $12 is less than one therapy copay and directly removes the barrier that wastes their current spending on failed trials.
How do you ship it?
MVP PLAN
“Start one ADHD med trial and one overdue assignment this week without zoning out.”
A simple mobile web app that provides one-tap symptom logging tied to cycle/insulin factors, guided micro-trials for ADHD meds with side-effect safety nets, daily executive function prompts calibrated to energy levels, and PCOS-specific validation modules to reduce diagnostic doubt.
Core Features
Weekly Roadmap
- •Build 60-second symptom logger with PCOS/ADHD presets
- •Simple energy level slider and daily prompt engine
- •Local storage for trial history
- •Create guided 7-day trial checklist template
- •Side-effect rating + alert system
- •Journal prompts for diagnostic doubt with evidence tracker
- •Link energy level to 3 micro academic/self-care tasks
- •Test with 5 simulated slump scenarios
- •Basic export for doctor sharing
- •Stripe integration for $12/mo
- •Recruit beta users from target subreddits
- •Onboarding flow under 90 seconds
Launch in r/PCOS, r/ADHD, r/adhdwomen, r/depression with free 14-day trials and success story templates from beta users.
RISKS & ASSUMPTIONS
Top Risks
Users may misinterpret guidance as medical advice leading to harm or legal issues during vulnerable med trials.
Users in deep slumps may not open the app or complete even 60-second logs.
Self-reported symptoms during dissociation may be inconsistent, reducing personalization value.
Users currently get emotional support for free on subreddits and may not convert to paid tool.
Should you build it?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 9/10 against 4 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "ai-powered", "automation", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "ADHDComorb Tracker: Guided Med Trials + Executive Function Starter for PCOS+ADHD" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.